Cedric Bloch will be back in TCR UK this season following his debut in the championship last year and will race full season in an Audi RS 3 LMS TCR DSG in the Gen 1 Cup. “I enjoyed the 2024 season and ...

Pedro Cardoso will defend his TCR South America title in 2025 after inking a deal to remain with PMO Racing. Cardoso secured the title for the first time last season after a year-long battle with Juan ...

Dave Elmstrom knew what he would do when the Trump administration’s resignation offer, titled “Fork in the Road,” landed in his inbox: take it. Elmstrom, a probationary employee at the U.S ...

The 2025 TCR Australia calendar was launched with a TBC as its finale, which has long been expected to be an appearance at the famous Guia circuit. That has now been confirmed by the new series ...

André The Giant is one the biggest (both figuratively and literally) stars in all of professional wrestling history. He was one of the key figures that was responsible for the major increase in ...

HMO Customer Racing’s fleet of Hyundai i30 N TCR cars at One Raceway. As first reported by Speedcafe, TCR Australia management informed competitors this week that it would not support Supercars ...

The program, termed the “Fork in the Road” and promoted by Trump adviser Elon Musk, originally had a deadline of Feb. 6 for workers to accept the offer. Last week, O’Toole temporarily ...

In his ruling, O'Toole wrote that the plaintiffs — the labor unions — lack standing to challenge the "Fork" directive, because they are not directly impacted by it. "Instead, they allege that ...

SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- On 12 Feb 2025 (Singapore Time), Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance ...

SINGAPORE, Feb. 11, 2025 /PRNewswire/ -- On 12 Feb 2025 (Singapore Time), Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...

NEW YORK – Lion TCR on Tuesday said the US Food and Drug Administration cleared its investigational new drug application seeking permission to begin a Phase II trial to test its mRNA-encoded T-cell ...